Arqit Quantum Inc.
Arqit Quantum Inc. (ARQQW) Financial Performance & Income Statement Overview
Review Arqit Quantum Inc. (ARQQW) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Arqit Quantum Inc. (ARQQW) Income Statement & Financial Overview
Review Arqit Quantum Inc. ARQQW income statement with detailed quarterly and annual figures.
Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $59500.00 | $59500.00 | $621000.00 | $0.00 |
Cost of Revenue | $567000.00 | $567000.00 | $0.00 | $0.00 |
Gross Profit | -$507500.00 | -$507500.00 | $621000.00 | $0.00 |
Gross Profit Ratio | -$8.53 | -$8.53 | $1.00 | $0.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $9.01M | $9.01M | $30.37M | $0.00 |
Operating Expenses | $7.81M | $7.81M | $30.37M | $0.00 |
Total Costs & Expenses | $8.38M | $8.38M | $30.37M | $0.00 |
Interest Income | $70000.00 | $70000.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $787500.00 | $787500.00 | $43812.00 | -$39586.00 |
EBITDA | -$9.52M | -$9.52M | -$26.23M | $0.00 |
EBITDA Ratio | -$160.02 | -$160.02 | -$42.24 | $0.00 |
Operating Income | -$8.32M | -$10.31M | -$29.75M | $0.00 |
Operating Income Ratio | -$139.82 | -$173.25 | -$47.90 | $0.00 |
Other Income/Expenses (Net) | $266500.00 | $266500.00 | -$22.46M | $0.00 |
Income Before Tax | -$8.05M | -$8.05M | -$52.21M | $0.00 |
Income Before Tax Ratio | -$135.34 | -$135.34 | -$84.08 | $0.00 |
Income Tax Expense | $0.00 | $0.00 | -$141000.00 | $0.00 |
Net Income | -$23.84M | -$8.05M | -$48.56M | $0.00 |
Net Income Ratio | -$400.61 | -$135.34 | -$78.19 | $0.00 |
EPS | -$0.42 | -$0.05 | -$0.30 | $0.00 |
Diluted EPS | -$1.24 | -$0.05 | -$0.30 | $0.00 |
Weighted Avg Shares Outstanding | $19.21M | $162.24M | $163.55M | $0.00 |
Weighted Avg Shares Outstanding (Diluted) | $6.49M | $162.24M | $163.55M | $0.00 |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q3 2023 to $59500.00 in Q2 2024. Gross profit remained healthy with margins at -853% in Q2 2024 compared to N/A in Q3 2023. Operating income hit -$8.32M last quarter, sustaining a consistent -13982% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$9.52M. Net income dropped to -$23.84M, while earnings per share reached -$0.42. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan